About
About Tianjin Ringpu Bio-Technology Co., Ltd
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and poultry, waterfowl, livestock, rumination, pets, washing and disinfection, active pharmaceutical ingredients product series. It also offers diagnosis and treatment services, such as epidemic diagnosis and testing, animal drug evaluation, and veterinary socialization. The company was founded in 1998 and is headquartered in Tianjin, China.
Visit company website
5 years, 5 months ago
Tianjin Ringpu Bio-Technology Co., Ltd is currently in a long term uptrend where the price is trading 20.1% above its 200 day moving average.
From a valuation standpoint, the stock is 45.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.3.
Tianjin Ringpu Bio-Technology Co., Ltd's total revenue rose by 24.4% to $539M since the same quarter in the previous year.
Its net income has increased by 193.6% to $146M since the same quarter in the previous year.
Finally, its free cash flow fell by 34.4% to $87M since the same quarter in the previous year.
Based on the above factors, Tianjin Ringpu Bio-Technology Co., Ltd gets an overall score of 4/5.